The global cosmetic peptide manufacturing market is expected to grow at a CAGR of 5.4% through 2034. The market value is projected to increase from US$ 244.2 million in 2024 to US$ 411.9 million by 2034. The cosmetic peptide manufacturing market was valued at US$ 233.7 million in 2023.
Attributes | Details |
---|---|
Cosmetic Peptide Manufacturing Market Size, 2023 | US$ 233.7 Million |
Estimated Market Size, 2024 | US$ 244.2 Million |
Projected Market Value, 2034 | US$ 411.9 Million |
Value-based CAGR (2024 to 2034) | 5.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Consumers are shifting toward a holistic approach to beauty, valuing products that not only provide immediate results but also support the skin's natural processes. Peptides, with their diverse benefits, fit well into this approach by promoting skin resilience from within.
Peptides can be tailored to address specific skin concerns, such as hyperpigmentation, acne, and inflammation. The emerging trend toward targeted solutions aligns with consumers seeking products that effectively address their unique needs.
The global cosmetic peptide manufacturing market recorded a CAGR of 3.2% from 2019 to 2023.
Historical Market Size, 2023 | US$ 233.7 Million |
---|---|
Historical CAGR, 2019 to 2023 | 3.2% |
Consumers are increasingly looking for safe and effective skin care-regime-based solutions, with high efficacy, as an alternative to procedure-based treatments for all ages to address their personal skin needs. Thus, to meet the rising personal care demand, key players are constantly researching and developing cosmetic solutions that are expected to be highly accepted by consumers.
In January 2022, BASF introduced Peptovitae™, an innovative series featuring four patented peptides that signify a groundbreaking advancement in scientifically formulated biomimetic peptides. This Peptovitae™ collection stands out by addressing a broader spectrum of skin concerns beyond the conventional scope associated with peptide use. Developed by BASF's Care Creations®, these new bioactives cater to various personal care skin needs. They target aging signs with Peptovitae™ Matrix, and enhance skin brightness with Peptovitae™ Bright. Along with this, they, provide relief for dry and itchy skin with Peptovitae™ Derma, and offer a calming and moisturizing effect with Peptovitae™ Clear. Through this initiative, BASF aims to empower consumers of all ages to realize their beauty aspirations.
Using these peptides as active ingredients, consumers can have access to products with proven efficacy. This is expected to boost the demand for cosmetic formulations, which in turn is expected to boost the cosmetic peptide manufacturing market’s growth in the coming years.
The growing popularity of derma cosmetic products that are based on natural ingredients is fueling growth in the market. This can be attributed to their ability to deliver solutions specific to consumers’ unique needs like microbiome approaches. Thus, the growing interest in derma cosmetics can offer beneficial opportunities for industries to invest in the cosmetic market. This is one of the crucial opportunities for the cosmetic peptide manufacturing market.
Growing awareness of using active ingredients in cosmetics and the production of bioactive peptides with natural resources is increasing the global market demand. Researchers are utilizing biotechnology sources to synthesize bioactive peptides. These developments are aimed at increasing the production efficiency of the bioactive peptide with high-quality expectations.
According to a research study, it was found that biotechnology sources have been highly accepted. Thus, projecting opportunistic ideas for peptide synthesis over other sources. Consequently, opportunities are present in the market for manufacturers to invest in cosmetic peptide synthesis using biotechnology.
Countries | CAGR (2024 to 2034) |
---|---|
United States | 5.7% |
Germany | 8.3% |
United Kingdom | 6.6% |
Japan | 6.5% |
China | 7.2% |
The United States dominates the North American market with a 94.6% market share in 2023. The United States is expected to exhibit a CAGR of 5.7% throughout the forecast period.
All these factors are consolidating market position of the United States on the global scale.
In 2023, China held a dominant global revenue in the East Asian market and contributed around US$ 19.82 million. The market is expected to record a CAGR of 7.2% over the forecast period.
China's cosmetic peptide manufacturing market is poised for lucrative opportunities, propelled by several factors. These include the country's burgeoning demand for beauty and skincare products, a rising middle-class population, and increased consumer awareness. Other key factors are as follows:
Germany occupies a 20.2% value share in Western Europe in 2023 and is expected to grow at a CAGR of 8.3% during the forecast period. Factors positioning Germany as a lucrative market for cosmetic peptide synthesis providers are as follows:
These factors are contributing to Germany’s leadership in the cosmetic peptide manufacturing market. Germany is thus significantly supporting the global market share.
The United Kingdom market is estimated to register a CAGR of 6.6% through 2034. Manufacturing of cosmetic peptides is rising in the country on account of the following factors:
Japan has been assessed to showcase a positive outlook in the market for cosmetic peptide manufacturing over the coming decade. The country is anticipated to rise at a CAGR of 6.5% through 2034. Top factors contributing to this optimistic trajectory are as follows:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Top Product | Signal Peptides |
---|---|
CAGR (2024 to 2034) | 5.5% |
The market value of signal peptides in cosmetic peptide manufacturing is US$ 129.3 million, representing a sizable 55.3% market share in 2023. The segment is expected to grow at a CAGR of 5.5% over the forecast period.
Signal peptides lead the cosmetic peptide manufacturing market by product due to their several benefits, scientific credibility, and their ability to address key skincare concerns.
Ongoing demand for effective and advanced skincare solutions positions signal peptides as a pivotal ingredient in the development of innovative cosmetic products. Signal peptides play a crucial role in cellular communication, transmitting specific signals to cells to initiate processes like collagen synthesis and skin regeneration.
Top Application | Anti-Aging Series Peptides |
---|---|
CAGR (2024 to 2034) | 6.6% |
The market value of the anti-aging series peptides in cosmetic peptide manufacturing is US$ 62.95 million, representing a sizable share of 26.9% of the market in 2023. The segment is expected to record a CAGR of 6.6% during the forecast period.
The anti-aging series peptides application is leading in the cosmetic peptide manufacturing market due to its:
The scientific backing and alignment with consumer preferences for advanced skincare contribute to its prominence in the market.
End Product | Skin Care |
---|---|
CAGR (2024 to 2034) | 5.5% |
The skin care segment accounted for a market share of 53.1% in 2023. The segment is projected to exhibit a CAGR of 5.5% over the forecast period.
The skin care end-product segment is leading in the cosmetic peptide manufacturing market. This can be attributed to its versatility, anti-aging properties, targeted solutions, and daily use integration. Manufacturers are developing effective and innovative skincare solutions in alignment with consumer preferences.
Peptides' effectiveness in addressing a range of skincare concerns positions them as a key ingredient in the formulation of skin care products. Thus, driving the leadership of the skin care segment.
End User | Cosmetic Manufacturers |
---|---|
CAGR (2024 to 2034) | 6.0% |
Cosmetic manufacturers have a considerable presence in the cosmetic peptide manufacturing market, accounting for a share of 47.6% of the market in 2023. The segment is predicted to expand at a CAGR of 6% during the forecast period.
The cosmetic manufacturers' end-user segment leads in the cosmetic peptide manufacturing market. Cosmetic manufacturers drive innovation and product development. These manufacturers invest in research and development to create new formulations that leverage the benefits of peptides. Their commitment to innovation positions them at the forefront of introducing novel products to the market.
The strategic combination of product launches and collaborations emerges as a robust and forward-thinking approach. Product launches signify innovation and responsiveness to evolving consumer needs. Thus, allowing companies to introduce cutting-edge formulations that leverage the latest advancements in peptide technology. These alliances enable cosmetic peptide manufacturers to access novel technologies, share expertise, and collectively contribute to groundbreaking developments.
Recent Developments
The global market value is set to reach US$ 244.2 million in 2024.
Global cosmetic peptide manufacturing demand is anticipated to rise at 5.4% CAGR through 2034.
The global cosmetic peptide manufacturing market is expected to reach US$ 411.9 million by 2034.
The skin care segment holds a significant share of the market.
Cosmetic manufacturers are the leading end users in the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion And Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Inclusions 4.1. Product Vs. Application Matrix 4.2. Number of Skin Clinics. by Region 4.3. Number of Dermatologists, by Country 4.4. Product Assessment 4.4.1. Product Adoption Analysis 4.4.2. Product USP's/Features Analysis 4.5. Regulatory Scenario 4.5.1. Regulatory Frameworks in North America 4.5.2. Regulatory Frameworks in Latin America 4.5.3. Regulatory Frameworks in Europe 4.5.4. Regulatory Frameworks in Japan 4.5.5. Regulatory Frameworks in China 4.5.6. Regulatory Frameworks in India 4.5.7. Regulatory Frameworks in Australia 4.5.8. Regulatory Frameworks in South Africa 4.5.9. Regulatory Frameworks in Russia 4.5.10. Regulatory Frameworks in BALKAN & BALTIC COUNTRIES 4.6. PESTLE Analysis, by Region 4.7. PORTER Analysis 4.8. Value Chain Analysis 4.9. Go-To-Market Strategy 4.10. Top Anti-Ageing Peptides List 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Rising per-Capita Healthcare Expenditure 5.1.2. R&D funding By Region 5.1.3. R&D funding By Country 5.1.4. Peptide Syntheses Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Adoption of Peptide in Cosmetics 5.2.2. Increasing Number of Dermatologist 5.2.3. Increasing Prevalence of Acne and Skin Pigmentation 5.2.4. Increasing Demand of Skin Care Products for UV Protection 5.2.5. Custom Peptide Service Cost 5.2.6. GDP Growth 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Value (US$ Million) Analysis, 2015 to 2023 6.2. Current and Future Market Value (US$ Million) Projections, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2015 to 2023 and Forecast 2024 to 2034, By Product 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Million) Analysis By Product, 2015 to 2023 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2024 to 2034 7.3.1. Signal peptides 7.3.2. Neurotransmitter inhibitors 7.3.3. Carrier Peptides 7.3.4. Enzyme inhibitor Peptides 7.3.5. Structural Peptides 7.3.6. Synthetic Antimicrobial peptides (AMPs) 7.3.7. Others 7.4. Market Attractiveness Analysis By Product 8. Global Market Analysis 2015 to 2023 and Forecast 2024 to 2034, by Application 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2023 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2024 to 2034 8.3.1. Hair/Eyelash/Eyebrow Care Series Peptide 8.3.2. Whitening Series Peptides 8.3.3. Anti-Aging Series Peptides 8.3.4. Skin Renewal Series Peptides 8.3.5. Anti-allergic & Anti-Inflammatory Series Peptides 8.3.6. Slimming & Breast Enhancement Peptides 8.3.7. Others 8.4. Market Attractiveness Analysis By Application 9. Global Market Analysis 2015 to 2023 and Forecast 2024 to 2034, By End Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By End Product, 2015 to 2023 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End Product, 2024 to 2034 9.3.1. Skin Care 9.3.1.1. Creams and Moisturizers 9.3.1.2. Sunscreen lotion 9.3.1.3. Serum 9.3.2. Hair Care 9.3.2.1. Cream 9.3.2.2. Serum 9.3.3. Eye Care 9.3.3.1. Cream 9.3.3.2. Serum 9.4. Market Attractiveness Analysis By End Product 10. Global Market Analysis 2015 to 2023 and Forecast 2024 to 2034, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2023 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2024 to 2034 10.3.1. Cosmetic manufacturers 10.3.2. Cosmetic Contract manufacturers 10.3.3. Biopharmaceutical Industries (personal care) 10.4. Market Attractiveness Analysis By End User 11. Global Market Analysis 2015 to 2023 and Forecast 2024 to 2034, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2023 11.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2024 to 2034 11.3.1. North America 11.3.2. Latin America 11.3.3. East Asia 11.3.4. South Asia & Pacific 11.3.5. Western Europe 11.3.6. Eastern Europe 11.3.7. Central Asia 11.3.8. Russia & Belarus 11.3.9. Balkan & Baltic Countries 11.3.10. Middle East & Africa 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015 to 2023 and Forecast 2024 to 2034 12.1. Introduction 12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 12.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 12.3.1. By Country 12.3.1.1. USA 12.3.1.2. Canada 12.3.2. By Product 12.3.3. By Application 12.3.4. By End Product 12.3.5. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By Application 12.4.4. By End Product 12.4.5. By End User 12.5. Drivers and Restraints - Impact Analysis 12.6. Country Level Analysis & Forecast 12.6.1. USA Market 12.6.1.1. Introduction 12.6.1.2. Market Analysis and Forecast by Market Taxonomy 12.6.1.2.1. By Product 12.6.1.2.2. By Application 12.6.1.2.3. By End Product 12.6.1.2.4. By End User 12.6.2. Canada Market 12.6.2.1. Introduction 12.6.2.2. Market Analysis and Forecast by Market Taxonomy 12.6.2.2.1. By Product 12.6.2.2.2. By Application 12.6.2.2.3. By End Product 12.6.2.2.4. By End User 13. Latin America Market Analysis 2015 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 13.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Argentina 13.3.1.3. Mexico 13.3.1.4. Rest of Latin America 13.3.2. By Product 13.3.3. By Application 13.3.4. By End Product 13.3.5. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Application 13.4.4. By End Product 13.4.5. By End User 13.5. Drivers and Restraints - Impact Analysis 13.6. Country Level Analysis & Forecast 13.6.1. Brazil Market 13.6.1.1. Introduction 13.6.1.2. Market Analysis and Forecast by Market Taxonomy 13.6.1.2.1. By Product 13.6.1.2.2. By Application 13.6.1.2.3. By End Product 13.6.1.2.4. By End User 13.6.2. Argentina Market 13.6.2.1. Introduction 13.6.2.2. Market Analysis and Forecast by Market Taxonomy 13.6.2.2.1. By Product 13.6.2.2.2. By Application 13.6.2.2.3. By End Product 13.6.2.2.4. By End User 13.6.3. Mexico Market 13.6.3.1. Introduction 13.6.3.2. Market Analysis and Forecast by Market Taxonomy 13.6.3.2.1. By Product 13.6.3.2.2. By Application 13.6.3.2.3. By End Product 13.6.3.2.4. By End User 14. Western Europe Market Analysis 2015 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 14.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. France 14.3.1.3. Spain 14.3.1.4. Italy 14.3.1.5. BENELUX 14.3.1.6. Nordics 14.3.1.7. United Kingdom 14.3.2. By Product 14.3.3. By End Product 14.3.4. By Application 14.3.5. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End Product 14.4.5. By End User 14.5. Drivers and Restraints - Impact Analysis 14.6. Country Level Analysis & Forecast 14.6.1. Germany Market 14.6.1.1. Introduction 14.6.1.2. Market Analysis and Forecast by Market Taxonomy 14.6.1.2.1. By Product 14.6.1.2.2. By Application 14.6.1.2.3. By End Product 14.6.1.2.4. By End User 14.6.2. France Market 14.6.2.1. Introduction 14.6.2.2. Market Analysis and Forecast by Market Taxonomy 14.6.2.2.1. By Product 14.6.2.2.2. By Application 14.6.2.2.3. By End Product 14.6.2.2.4. By End User 14.6.3. Italy Market 14.6.3.1. Introduction 14.6.3.2. Market Analysis and Forecast by Market Taxonomy 14.6.3.2.1. By Product 14.6.3.2.2. By Application 14.6.3.2.3. By End Product 14.6.3.2.4. By End User 14.6.4. Spain Market 14.6.4.1. Introduction 14.6.4.2. Market Analysis and Forecast by Market Taxonomy 14.6.4.2.1. By Product 14.6.4.2.2. By Application 14.6.4.2.3. By End Product 14.6.4.2.4. By End User 14.6.5. UK Market 14.6.5.1. Introduction 14.6.5.2. Market Analysis and Forecast by Market Taxonomy 14.6.5.2.1. By Product 14.6.5.2.2. By Application 14.6.5.2.3. By End Product 14.6.5.2.4. By End User 14.6.6. Benelux Union Market 14.6.6.1. Introduction 14.6.6.2. Market Analysis and Forecast by Market Taxonomy 14.6.6.2.1. By Product 14.6.6.2.2. By Application 14.6.6.2.3. By End Product 14.6.6.2.4. By End User 14.6.7. Nordic Countries Market 14.6.7.1. Introduction 14.6.7.2. Market Analysis and Forecast by Market Taxonomy 14.6.7.2.1. By Product 14.6.7.2.2. By Application 14.6.7.2.3. By End Product 14.6.7.2.4. By End User 15. Eastern Europe Market Analysis 2015 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 15.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. Poland 15.3.1.2. Hungary 15.3.1.3. Romania 15.3.1.4. Czech Republic 15.3.1.5. Others 15.3.2. By Product 15.3.3. By Application 15.3.4. By End Product 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End Product 15.4.5. By End User 15.5. Drivers and Restraints - Impact Analysis 15.6. Country Level Analysis & Forecast 15.6.1. Poland Market 15.6.1.1. Introduction 15.6.1.2. Market Analysis and Forecast by Market Taxonomy 15.6.1.2.1. By Product 15.6.1.2.2. By Application 15.6.1.2.3. By End Product 15.6.1.2.4. By End User 15.6.2. Hungary Market 15.6.2.1. Introduction 15.6.2.2. Market Analysis and Forecast by Market Taxonomy 15.6.2.2.1. By Product 15.6.2.2.2. By Application 15.6.2.2.3. By End Product 15.6.2.2.4. By End User 15.6.3. Romania Market 15.6.3.1. Introduction 15.6.3.2. Market Analysis and Forecast by Market Taxonomy 15.6.3.2.1. By Product 15.6.3.2.2. By Application 15.6.3.2.3. By End Product 15.6.3.2.4. By End User 15.6.4. Czech Republic Market 15.6.4.1. Introduction 15.6.4.2. Market Analysis and Forecast by Market Taxonomy 15.6.4.2.1. By Product 15.6.4.2.2. By Application 15.6.4.2.3. By End Product 15.6.4.2.4. By End User 16. South Asia Market Analysis 2015 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 16.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Thailand 16.3.1.4. Philippines 16.3.1.5. Malaysia 16.3.1.6. Vietnam 16.3.1.7. Rest of ASEAN 16.3.1.8. Australia & New Zealand 16.3.2. By Product 16.3.3. By Application 16.3.4. By End Product 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End Product 16.4.5. By End User 16.5. Drivers and Restraints - Impact Analysis 16.6. Country Level Analysis & Forecast 16.6.1. India Market 16.6.1.1. Introduction 16.6.1.2. Market Analysis and Forecast by Market Taxonomy 16.6.1.2.1. By Product 16.6.1.2.2. By Application 16.6.1.2.3. By End Product 16.6.1.2.4. By End User 16.6.2. Indonesia Market 16.6.2.1. Introduction 16.6.2.2. Market Analysis and Forecast by Market Taxonomy 16.6.2.2.1. By Product 16.6.2.2.2. By Application 16.6.2.2.3. By End Product 16.6.2.2.4. By End User 16.6.3. Malaysia Market 16.6.3.1. Introduction 16.6.3.2. Market Analysis and Forecast by Market Taxonomy 16.6.3.2.1. By Product 16.6.3.2.2. By Application 16.6.3.2.3. By End Product 16.6.3.2.4. By End User 16.6.4. Thailand Market 16.6.4.1. Introduction 16.6.4.2. Market Analysis and Forecast by Market Taxonomy 16.6.4.2.1. By Product 16.6.4.2.2. By Application 16.6.4.2.3. By End Product 16.6.4.2.4. By End User 16.6.5. Philippines Market 16.6.5.1. Introduction 16.6.5.2. Market Analysis and Forecast by Market Taxonomy 16.6.5.2.1. By Product 16.6.5.2.2. By Application 16.6.5.2.3. By End Product 16.6.5.2.4. By End User 16.6.6. Vietnam Market 16.6.6.1. Introduction 16.6.6.2. Market Analysis and Forecast by Market Taxonomy 16.6.6.2.1. By Product 16.6.6.2.2. By Application 16.6.6.2.3. By End Product 16.6.6.2.4. By End User 16.6.7. Australia & New Zealand Market 16.6.7.1. Introduction 16.6.7.2. Market Analysis and Forecast by Market Taxonomy 16.6.7.2.1. By Product 16.6.7.2.2. By Application 16.6.7.2.3. By End Product 16.6.7.2.4. By End User 17. East Asia Market Analysis 2015 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 17.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Application 17.3.4. By End Product 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End Product 17.4.5. By End User 17.5. Drivers and Restraints - Impact Analysis 17.6. Country Level Analysis & Forecast 17.6.1. China Market 17.6.1.1. Introduction 17.6.1.2. Market Analysis and Forecast by Market Taxonomy 17.6.1.2.1. By Product 17.6.1.2.2. By Application 17.6.1.2.3. By End Product 17.6.1.2.4. By End User 17.6.2. Japan Market 17.6.2.1. Introduction 17.6.2.2. Market Analysis and Forecast by Market Taxonomy 17.6.2.2.1. By Product 17.6.2.2.2. By Application 17.6.2.2.3. By End Product 17.6.2.2.4. By End User 17.6.3. South Korea Market 17.6.3.1. Introduction 17.6.3.2. Market Analysis and Forecast by Market Taxonomy 17.6.3.2.1. By Product 17.6.3.2.2. By Application 17.6.3.2.3. By End Product 17.6.3.2.4. By End User 18. Central Asia Market Analysis 2015 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 18.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Product 18.3.2. By Application 18.3.3. By End Product 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Product 18.4.2. By Application 18.4.3. By End Product 18.4.4. By End User 18.5. Drivers and Restraints - Impact Analysis 19. Russia & Belarus Market Analysis 2015 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 19.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 19.3.1. By Product 19.3.2. By Application 19.3.3. By End Product 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Product 19.4.2. By Application 19.4.3. By End Product 19.4.4. By End User 19.5. Drivers and Restraints - Impact Analysis 20. Balkan & Baltic Countries Market Analysis 2015 to 2023 and Forecast 2024 to 2034 20.1. Introduction 20.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 20.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 20.3.1. By Product 20.3.2. By Application 20.3.3. By End Product 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Product 20.4.2. By Application 20.4.3. By End Product 20.4.4. By End User 20.5. Drivers and Restraints - Impact Analysis 21. Middle East and Africa (MEA) Market Analysis 2015 to 2023 and Forecast 2024 to 2034 21.1. Introduction 21.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2023 21.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2024 to 2034 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Israel 21.3.1.3. Türkiye 21.3.1.4. South & Northern Africa 21.3.1.5. Rest of MEA 21.3.2. By Product 21.3.3. By Application 21.3.4. By End Product 21.3.5. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Application 21.4.4. By End Product 21.4.5. By End User 21.5. Drivers and Restraints - Impact Analysis 21.6. Country Level Analysis & Forecast 21.6.1. GCC Countries Market 21.6.1.1. Introduction 21.6.1.2. Market Analysis and Forecast by Market Taxonomy 21.6.1.2.1. By Product 21.6.1.2.2. By Application 21.6.1.2.3. By End Product 21.6.1.2.4. By End User 21.6.2. Israel Market 21.6.2.1. Introduction 21.6.2.2. Market Analysis and Forecast by Market Taxonomy 21.6.2.2.1. By Product 21.6.2.2.2. By Application 21.6.2.2.3. By End Product 21.6.2.2.4. By End User 21.6.3. Türkiye Market 21.6.3.1. Introduction 21.6.3.2. Market Analysis and Forecast by Market Taxonomy 21.6.3.2.1. By Product 21.6.3.2.2. By Application 21.6.3.2.3. By End Product 21.6.3.2.4. By End User 21.6.4. South & North Africa Market 21.6.4.1. Introduction 21.6.4.2. Market Analysis and Forecast by Market Taxonomy 21.6.4.2.1. By Product 21.6.4.2.2. By Application 21.6.4.2.3. By End Product 21.6.4.2.4. By End User 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 22.3.1. By Regional footprint of Players 22.3.2. By Product footprint of Players 22.3.3. By Channel footprint of Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Branding & Promotional strategies, By Players 23.4. Key Development Analysis 23.5. Competition Deep Dive 23.5.1. Croda International plc 23.5.1.1. Overview 23.5.1.2. Product Portfolio 23.5.1.3. Key Financials 23.5.1.4. Sales Footprint 23.5.1.5. Analysis Commentary 23.5.1.6. Strategy Overview 23.5.2. Ashland 23.5.3. DSM [Koninklijke DSM NV] 23.5.4. Bachem 23.5.5. GenScript Biotech Corporation 23.5.6. BASF SE 23.5.7. Geltor 23.5.8. The Lubrizol Corporation 23.5.9. Symrise 23.5.10. Bio Basic Inc. 23.5.11. Regeron Inc. 23.5.12. Merck KGaA 23.5.13. RS Synthesis, LLC 23.5.14. CSBio Company Inc. 23.5.15. Creative Peptides 23.5.16. Spec Chem Industry Inc. 23.5.17. LipoTrue, SL 23.5.18. Fibroheal 23.5.19. Seiwa Kasei Co., Ltd. 23.5.20. Silab 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports